Literature DB >> 10898668

Impact of antimicrobial agents and chemotherapy from 1972 to 1998.

M N Swartz1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10898668      PMCID： PMC90006          DOI： 10.1128/AAC.44.8.2009-2016.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  20 in total

Review 1.  Once-daily aminoglycoside therapy.

Authors:  D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 2.  Antimicrobial resistance among enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

Review 3.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Treatment of chronic typhoid carriers with ampicillin.

Authors:  W D Johnson; E W Hook; E Lindsey; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

Review 6.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

7.  Antimicrobial therapy of experimental enterococcal endocarditis.

Authors:  E W Hook; R B Roberts; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

8.  Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods.

Authors:  E Hershberger; J R Aeschlimann; T Moldovan; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Susceptibility of the Bacteroides fragilis group in the United States in 1981.

Authors:  F P Tally; G J Cuchural; N V Jacobus; S L Gorbach; K E Aldridge; T J Cleary; S M Finegold; G B Hill; P B Iannini; R V McCloskey; J P O'Keefe; C L Pierson
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

10.  Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721.

Authors:  A M Slee; M A Wuonola; R J McRipley; I Zajac; M J Zawada; P T Bartholomew; W A Gregory; M Forbes
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191
View more
  2 in total

1.  Novel concentration-killing curve method for estimation of bactericidal potency of antibiotics in an in vitro dynamic model.

Authors:  Y Q Liu; Y Z Zhang; P J Gao
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Antibacterial cyclic D,L-alpha-glycopeptides.

Authors:  Leila Motiei; Shai Rahimipour; Desiree A Thayer; Chi-Huey Wong; M Reza Ghadiri
Journal:  Chem Commun (Camb)       Date:  2009-05-29       Impact factor: 6.222
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.